Abstract:Hepatic stellate cells are the major cellular sources of extracellular matrix in chronic liver diseases leading to fibrosis. We explored the antifibrogenic effect of two histone deacetylase inhibitors, sodium butyrate and trichostatin A (TSA), on this cell type in vitro. Primary hepatic stellate cells as well as culture activated cells were exposed to butyrate (0.01-1 mmol/L) or TSA (1-100 nmol/L); their effect on collagen types I and III and smooth muscle alpha-actin was examined by quantitative immunoprecipitation and by Northern analysis. Their antiproliferative effect was examined by 3H-thymidine incorporation and cell counting. Hyperacetylation of histones was demonstrated by acid urea/Triton-X-100 (AUT) polyacrylamide gel electrophoresis. Possible cytotoxic effects were judged on stellate cells by evaluating de novo total protein synthesis, and on hepatocytes by measuring lactate dehydrogenase (LDH) leakage, albumin secretion, and epoxide hydrolase and ethoxycoumarin O-deethylase activity. TSA at 100 nmol/L and butyrate at 1 mmol/L retarded the morphological changes characteristic for activation of primary stellate cells. TSA at 100 nmol/L inhibited synthesis of collagen types I and III and smooth muscle alpha-actin by 62%, 70%, and 88%. Butyrate at 1 mmol/L showed a modest inhibitory effect on collagen type III and smooth muscle alpha-actin, but had no effect on collagen type I. Northern analysis suggested that these inhibitory effects on collagen type III and smooth muscle alpha-actin were transcriptional, while the effect on collagen type I was largely posttranscriptional. At 100 nmol/L, TSA strongly suppressed proliferation of primary hepatic stellate cells. Inhibition of activation of stellate cells was preceded by hyperacetylation of histone H4. When tested on cells at day 14 in culture, butyrate had no inhibitory effects on the synthesis of collagens or smooth muscle alpha-actin. One hundred or 10 nmol/L TSA modestly inhibited the synthesis of collagens type I (-24%,-22%) and III (-34%,-22%), and smooth muscle alpha-actin (-27%,-12%). We conclude that TSA inhibits transdifferentiation of stellate cells into myofibroblasts by interfering with the level of acetylation of histone H4.

Effects of Histone Deacetylase Inhibitor Trichostatin A on Proliferation and Adipogenic Differentiation of C3H10T1/2 Mesenchymal Stem Cells

Effects of trichostatin A on the expressions of inflammatory cytokines and toll-like receptor 4 and the acetylation of nuclear factor-κB induced by lipopolysaccharide in macrophage

Inhibition of histone deacetylases class I improves adipogenic differentiation of human periodontal ligament cells

The effect of trichostatin A on the proliferation and p16INK4a promoter methylation and the p16INK4amRNA expression of adenoid cystic carcinoma ACC-2 cell line

Effect of Trichostatin A on proliferation and migration of vascular smooth muscle cells

HDAC Inhibitor TSA Induced Apoptosis and Growth Arrest in Breast Cancer Cells

Effects of Histone Deacetylase Inhibitor on Apoptosis of Osteosarcoma MNNG/HOS Cells in Vitro

Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition.

Antitumor Activity of Histone Deacetylase Inhibitor Trichostatin A in Osteosarcoma Cells

Trichostatin A stabilizes the expression of pluripotent genes in human mesenchymal stem cells during ex vivo expansion.

A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture

Trichostatin A Improves Insulin Stimulated Glucose Utilization and Insulin Signaling Transduction Through the Repression of HDAC2.

TSA Increases C/EBP-α Expression by Increasing Its Lysine Acetylation in Hepatic Stellate Cells

Effects of Trichostatin on Apoptosis and Expression of DAPK1 Gene in Human Gastric Cancer SGC-7901 Cells

Role of P38, ERK1/2, Focal Adhesion Kinase, RhoA/ROCK and Cytoskeleton in the Adipogenesis of Human Mesenchymal Stem Cells.

Trichostatin A Inhibits the Activation of Hepatic Stellate Cells by Increasing C/EBP-α Acetylation in Vivo and in Vitro.

Cytotoxicity and Inhibitory Effects of Low-Concentration Triclosan on Adipogenic Differentiation of Human Mesenchymal Stem Cells

PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells.

Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner.

Effect of trichostatin A on the proliferation and migration of osteosarcoma cell lines and its mechanism

Effects of Trichostatin A on Expression of Proinflammatory Cytokines in Hearts and Cardiac Function in Rats with Heart Failure